ENTRY       D09745            Mixture   Drug
NAME        Valsartan and amlodipine besilate;
            Exforge (TN)
PRODUCT     EXFORGE (Novartis Pharmaceuticals Corporation)
  GENERIC   AMLODIPINE AND VALSARTAN (Alembic Pharmaceuticals Limited)
            AMLODIPINE AND VALSARTAN (Alembic Pharmaceuticals)
            AMLODIPINE AND VALSARTAN (Aurobindo Pharma Limited)
            AMLODIPINE AND VALSARTAN (Golden State Medical Supply)
            AMLODIPINE AND VALSARTAN (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            AMLODIPINE AND VALSARTAN (Lupin Pharmaceuticals)
            AMLODIPINE AND VALSARTAN (Mylan Pharmaceuticals)
            AMLODIPINE AND VALSARTAN (Strides Pharma Science Limited)
COMPONENT   Valsartan [DR:D00400], Amlodipine besilate [DR:D00615]
CLASS       Cardiovascular agent
             DG01925  Renin-angiotensin system inhibitor
             DG03231  Antihypertensive
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Therapeutic category: 2149
            ATC code: C09DB01
            Product: D09745<JP/US>
EFFICACY    Antihypertensive
  DISEASE   Hypertension [DS:H01633]
COMMENT     Anmlodipine is metabolized by CYP3A4.
METABOLISM  Enzyme: CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
               C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
                C09DB Angiotensin II receptor blockers (ARBs) and calcium channel blockers
                 C09DB01 Valsartan and amlodipine
                  D09745  Valsartan and amlodipine besilate &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Cardiovascular Combinations
               Amlodipine/ Valsartan
                D09745  Valsartan and amlodipine besilate
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               214  Antihypertensives
                2149  Others
                 D09745  Valsartan and amlodipine besilate
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01925  Renin-angiotensin system inhibitor
               D09745  Valsartan and amlodipine besilate
              DG03231  Antihypertensive
               D09745  Valsartan and amlodipine besilate
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D09745  Valsartan and amlodipine besilate
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D09745  Valsartan and amlodipine besilate
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09745
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09745
DBLINKS     PubChem: 124490485
///
